California Stem-Cell Measure is Starting an Academic Gold Rush
Researchers and start-ups have are gravitating toward the state where voters approved approved a plan to spend $3 billion on studies that may lead to cures for an array of diseases.
Researchers and start-ups have are gravitating toward the state where voters approved approved a plan to spend $3 billion on studies that may lead to cures for an array of diseases.
Keep Reading
Most Popular
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.